Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
AARTIPHARM
AARTIPHARM

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM
BSE: 543748
Sector: Healthcare
Industry: Pharmaceuticals
823.65-5.1 (-0.62%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

46.3 / 100

Value Score

36.7 / 100

Price Momentum Score

81.3 / 100

QVM Score

56.9 / 100

Key Metrics

Market Cap
7468.86
P/E (TTM)
35.04
P/B
3.52
P/S (TTM)
3.79
EV/EBITDA
18.77
CAPE (5Y)
38.10
ROE (TTM)
8.49
ROCE (TTM)
11.19
ROA (TTM)
5.47
Avg 3Y ROE
12.04
Earnings 3Y CAGR
3.97
Sales 3Y CAGR
0.39
Sales 5Y CAGR
-
Debt/Equity
0.37
Consensus TP
740.00
Strong Buy %
-
Promoter Holding
39.66
Pledged %
11.98

Share Price

Track Aarti Pharmalabs Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

823.65-5.1 (-0.62%)
-1.04% in past 1 year
1 Week returns: -6.08 %
Low
782.0
High
879.0
1 Month returns: -12.39 %
Low
782.0
High
1,002.4
1 Year returns: -1.74 %
Low
583.8
High
1,002.4
3 Year CAGR: 29.22 %
Low
371.1
High
1,002.4
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Aarti Pharmalabs Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Strong price momentum

Price Momentum score of 81.3 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

81.3 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 3 financial years

What is Dividend streak?

Negative
Expensive and at a premium to industry median P/E

PE TTM of 35.04 indicates that the stock is expensive on a standalone basis and is at a 15.0% premium to industry median P/E

What is P/E Ratio?

Median: 30.47
Value 35.04
-0.82614.73
Low dividend yield

The company has a low dividend yield of 0.42%

What is Dividend yield?

Neutral
Company's earnings are of moderate quality

Earnings quality score of 57.4 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

57.4 / 100

No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Aarti Pharmalabs Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
01k2k3k1.9 K CrMar 20231.9 K CrMar 20242.1 K CrMar 20251.8 K CrMar 2026
Profit After Tax FY
00k0k0k193.5 CrMar 2023216.9 CrMar 2024272.4 CrMar 2025174.7 CrMar 2026
ROE FY
0%5%10%15%13.1%Mar 202313.1%Mar 202414.5%Mar 20258.5%Mar 2026
EBITDA FY
00k0k1k342.4 CrMar 2023386.0 CrMar 2024464.4 CrMar 2025402.4 CrMar 2026

Aarti Pharmalabs Ltd. Shareholding Pattern

Quarterly breakdown of Aarti Pharmalabs Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
45.98
45.98
46.30
46.46
46.46
46.46
46.10
44.66
44.29
43.72
42.88
43.10
43.08
42.86
39.66
Indian Promoter
45.81
45.81
46.13
46.29
46.29
46.29
45.93
44.48
44.12
43.55
42.71
42.93
42.91
42.69
39.49
Foreign Promoter
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
0.17
Institutions
21.38
18.09
18.97
18.08
18.30
18.53
18.74
19.01
14.89
15.15
14.99
15.35
15.81
15.39
16.56
Mutual Funds / UTI
5.11
2.72
2.67
2.05
2.72
4.69
4.93
3.93
0.78
0.90
0.79
1.09
0.80
0.79
0.60
FI/Bank/Insurance
7.75
7.08
7.05
7.05
6.51
6.09
6.09
6.09
6.09
6.03
5.30
5.30
5.30
5.30
4.75
Govt
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
FII
7.69
7.43
8.45
8.17
8.33
7.07
7.38
8.64
7.36
7.34
8.02
7.68
8.39
8.17
8.16
Other Institutions
0.82
0.85
0.79
0.81
0.74
0.68
0.33
0.34
0.65
0.87
0.86
1.27
1.30
1.12
3.05
Non-Institution
32.64
35.93
34.73
35.46
35.23
35.00
35.16
36.33
40.82
41.12
42.13
41.54
41.11
41.75
43.78
Bodies Corporate
1.09
2.19
2.10
2.13
1.91
1.72
1.98
2.61
2.78
2.96
2.98
2.73
2.81
3.20
4.06
Others (incl. Retail)
No. of shareholders
31.55
2,75,201
33.74
2,56,868
32.63
2,25,383
33.33
2,14,941
33.32
2,03,306
33.28
1,88,258
33.18
1,84,672
33.72
1,84,038
38.04
1,95,073
38.16
1,85,756
39.15
1,89,084
38.81
1,83,171
38.30
1,78,073
38.55
1,75,218
39.72
1,72,913

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence
#IndexWeightRank
1Nifty Microcap 2500.55%51 / 250
2Nifty Total Market0.03%469 / 746

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Aarti Pharmalabs Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
Relacion Trusteeship Services Private Limited
Promoter Group
September-2026
Market Sale (Disposal)
22nd Sep 2026
0.69 %₹ 818.796.28 lac₹ 51.38 cr
Gloire Trusteeship Services Private Limited
Promoter Group
September-2026
Market Sale (Disposal)
22nd Sep 2026
0.68 %₹ 818.836.25 lac₹ 51.14 cr
Safechem Enterprises Private Limited
Promoter Group
July-2026
Market Sale (Disposal)
2nd Jul 2026
0.70 %₹ 682.6688.27 k₹ 6.03 cr
Mirik Rajendra Gogri
Promoter Group
March-2026
Market Sale (Disposal)
4th Mar 2026
1.15 %₹ 705.739.00 k₹ 63.52 lac
Narendra J Salvi
KMP
December-2025
Market Sale (Disposal)
15th Dec 2025
0.01 %₹ 722.113.00 k₹ 21.66 lac
Hetal Gogri Gala
Promoter Group
December-2025
Market Purchase (Acquisition)
5th Dec 2025
3.10 %₹ 687.5664.00₹ 44.00 k
Hetal Gogri Gala
Promoter Group
December-2025
Market Purchase (Acquisition)
4th Dec 2025
3.03 %₹ 700.2063.77 k₹ 4.47 cr
Hetal Gogri Gala
Promoter Group
December-2025
Market Purchase (Acquisition)
3rd Dec 2025
2.89 %₹ 700.3981.95 k₹ 5.74 cr
Hetal Gogri Gala
Promoter Group
December-2025
Market Purchase (Acquisition)
3rd Dec 2025
2.97 %₹ 700.2554.28 k₹ 3.80 cr
Manjula M. Sangoi
Directors Immediate Relative
September-2025
Market Sale (Disposal)
26th Sep 2025
0.02 %₹ 881.245.00 k₹ 44.06 lac
…

Corporate Actions

History of Aarti Pharmalabs Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Dividend₹ 2/share
    Record date: 15th Sep 2026Ex-date: 15th Sep 2026
    Announced on: 25th May 2026
  2. Dividend₹ 1.50/share
    Record date: 16th Feb 2026Ex-date: 16th Feb 2026
    Announced on: 9th Feb 2026
  3. Dividend₹ 2.50/share
    Record date: 15th Sep 2025Ex-date: 15th Sep 2025
    Announced on: 11th May 2025
  4. Dividend₹ 2.50/share
    Record date: 14th Feb 2025Ex-date: 14th Feb 2025
    Announced on: 5th Feb 2025
  5. Dividend₹ 1/share
    Record date: 31st Jul 2024Ex-date: 31st Jul 2024
    Announced on: 13th May 2024

Company Profile

Overview of Aarti Pharmalabs Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemic...
Key personnel
Rakeshwar Bandichhor
Chief Scientific Officer - Research and Development
Mr. Jeevan Bhargav Mondkar
Company Secretary and Compliance Officer
Shri. Rashesh Chandrakant GogriD
Chairman of the Board, Managing Director
Smt. Hetal Gogri GalaD
Executive Vice Chairman of the Board
Mr. Chetan Bipin GandhiD
Director
Shri. Narendra Jagannath SalviD
Director
Shri. Parimal DesaiD
Non-Executive Director
Smt. Nehal GarewalD
Non-Executive Non-Independent Director
View all
Incorporated on
22 Nov 2019
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
2,421
IPO date
30 Jan 2023
Free Float
5,07,80,500
Phone no.
+912269436100
Address
2nd Floor, 204, Udyog Kshetra, Mulund - Goregaon Link Rd, Mulund (W), MUMBAI, 400080, India

Frequently Asked Questions

What is the current share price of Aarti Pharmalabs Ltd.?
The current share price of Aarti Pharmalabs Ltd. is ₹ 823.65 as of 23 Oct 2026.
What is the market capitalisation of Aarti Pharmalabs Ltd.?
The market capitalisation of Aarti Pharmalabs Ltd. stands at ₹ 7,468.86 Cr.
What is the PE ratio of Aarti Pharmalabs Ltd.?
The Price-to-Earnings (PE) ratio of Aarti Pharmalabs Ltd. is 35.04 as of the latest trailing twelve months data.
What is the ROE and ROCE of Aarti Pharmalabs Ltd.?
Aarti Pharmalabs Ltd. has a Return on Equity (ROE) of 8.49% and a Return on Capital Employed (ROCE) of 11.19% as per the latest financial reports.
What is the 52-week high and low of Aarti Pharmalabs Ltd.?
The 52-week high of Aarti Pharmalabs Ltd. is - and the 52-week low is -.
What is the dividend yield of Aarti Pharmalabs Ltd.?
The dividend yield of Aarti Pharmalabs Ltd. is 0.42% based on the current market price.
What is the FII and DII holding in Aarti Pharmalabs Ltd.?
Foreign Institutional Investors (FII) hold 8.16%, Domestic Institutional Investors (DII) hold 5.35% and retail/public investors hold 39.72% of Aarti Pharmalabs Ltd. shares.
What sector does Aarti Pharmalabs Ltd. belong to?
Aarti Pharmalabs Ltd. operates in the Healthcare sector.
What is the beta of Aarti Pharmalabs Ltd.?
The beta of Aarti Pharmalabs Ltd. is 1.22, indicating its price volatility relative to the broader market. Over the past 1 year, Aarti Pharmalabs Ltd. has delivered an absolute return of -1.55%.
What is the RSI of Aarti Pharmalabs Ltd.?
The 14-day Relative Strength Index (RSI) of Aarti Pharmalabs Ltd. is 41.07, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.